AB-729 是一种siRNA，通过RNA 干扰 (
RNAi)抑制病毒复制并减少
HBV抗原。AB-729 与 N-乙酰半乳糖胺 (GalNAc) 配体的三聚体结合，通过去唾液酸糖蛋白受体 (ASGR) 促进肝细胞摄取 。
| 生物活性 |
AB-729 is a siRNA specifically designed to inhibit viral replication and reducesHBVantigens[1][2]. AB-729 conjugates to a trimer of N-acetylgalactosamine (GalNAc) ligand that promotes uptake into hepatocytes via the asialoglycoprotein receptor (ASGR).
|
| Clinical Trial |
|
| CAS 号 |
|
| 运输条件 |
Room temperature in continental US; may vary elsewhere.
|
| 储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis.
|
m.cnreagent.com
